SecBot SecBot

PETS

PETMED EXPRESS INC
Nasdaq· Retail-Drug Stores and Proprietary Stores· Inc. FL· CIK 0001040130 Consumer & Retail
$1.16 −0.06 (−4.92%)
Oct 26 4:00 PM ET · prev $1.22
Market cap
$25.6M
Nano cap
Consensus
Sell
0% Buy or better · 6 analysts
Median target
$1.40
+21% · range $1.40–1.40
Next earnings
Nov 11
in 16 days · EPS est. −$0.11
1 year
−56.4%
from $2.66 · Oct 27
30 days
−17.7%
from $1.41
52-week range
$1.15–3.90
−70% from high · low Oct 19
Avg volume 20D
118.8K
Oct 14 spike 416.8K
Short interest
691.5K
≈3.2% of shares · +21.5%
Days to cover
4.2
at average volume
Insider net
+$43.7K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 4 reports · 90 days
Balance 0 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 3/4 ·Next Earnings date, Nov 11, 2026
Strongest NEUTRAL PetMed Express (PETS) appointed Jeff Willard as permanent CEO/President effective September 28, 2026…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $43.7K at an average $1.75. No open-market sales. Price is 34% below their cost.

  • InstitutionsBEARISH

    Q2 2026: 1 added (0 new), 8 trimmed or exited.

  • AnalystsBEARISH

    0 of 6 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.060 → −$0.110 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersBUILDING

    Short interest +21.5% to 691.5K shares. 4.2 days to cover, ≈3.2% of shares.

  • TrendDOWNTREND

    24% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADANEAR_EXIT30—
FEDERATED HERMES, INC.TRIM212,170$407.4K
UBS Group AGTRIM138,330$265.6K
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPTRIM79,503$152.6K
DIMENSIONAL FUND ADVISORS LPTRIM60,353$115.8K
AMERICAN CENTURY COMPANIES INCTRIM12,871$24.7K
JONES FINANCIAL COMPANIES LLLPADD415$730.00
FMR LLCTRIM60$115.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

6 analysts
Sell 0% rate it Buy or better
Strong Buy0Buy0Hold2Sell2Strong Sell2
12-month targets · 1 analysts

Price is below the lowest target. Median implies +21%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 25, 2026Morgan Stanley
MAINTAIN
MAINTAINUnderweight

Insider ledger

Form 4
$43.7K
bought · 1 insider
$0
sold · 0 insiders
−33.7%
vs their $1.75 cost
DateInsiderTypeValue
Sep 28, 2026
Willard Jeffrey Allen
CEO and President
AWARD250,000 sh
Sep 28, 2026
Willard Jeffrey Allen
CEO and President
AWARD250,000 sh
Sep 17, 2026
Elkeles Tamar
Director
AWARD49,923 sh
Aug 11, 2026
LaCamp James
Director
AWARD55,555 sh
Aug 11, 2026
Batushansky Peter
Director
AWARD55,555 sh
Aug 11, 2026
Mennen Justin L.
Director
AWARD55,555 sh
Aug 11, 2026
Campbell Leslie C.G.
Interim CEO and President
AWARD60,000 sh
Jun 26, 2026
KRULIK DOUGLAS
CAO and Interim CFO
AWARD32,500 sh

Earnings setup

Estimates
Nov 11
reports in 16 days
−$0.11
EPS estimate, this quarter
−83%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.11-$0.11–-$0.11-83.3%$0.00
Next Q-$0.16-$0.16–-$0.16-45.5%$0.00
Current FY🔒 Fresh data, subscribers only
Next FY-$0.35-$0.35–-$0.35-488.9%$152.5M

Short side

FINRA· Sep 30, 2026
691,516
shares short
+21.5%
vs prior settlement
4.2
days to cover
≈3.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 2, 2026 Press
PetMed Express granted equity inducement awards to two newly hired executives: CEO Jeff Willard received 250,000…
Impact 2/10
Oct 2, 2026 Activist
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent c
Sep 28, 2026 Insider
Willard Jeffrey Allen was granted 250,000 shares
CEO and President
Sep 28, 2026 Insider
Willard Jeffrey Allen was granted 250,000 shares
CEO and President
Sep 21, 2026 SEC
PetMed Express appointed Tamar Elkeles, Ph.D., as an independent director and Chair of the Compensation and Human…
8-K — Impact 2/10
Sep 17, 2026 SEC
PetMed Express (PETS) appointed Jeff Willard as permanent CEO/President effective September 28, 2026, replacing…
8-K — Impact 4/10
Sep 17, 2026 Press
PetMed Express appointed Jeff Willard as CEO and President effective September 28, 2026, succeeding interim CEO Leslie…
Impact 3/10
Sep 17, 2026 Insider
Elkeles Tamar was granted 49,923 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
PETS Q2 2027 Earnings Scheduled — 2026-11-11
Recent
Oct 2, 2026
Activist
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today…
Sep 21, 2026
Press release
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution…
Sep 17, 2026
Leadership
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
Justin Mennen to Succeed Leslie C.G. Campbell as Chair of the Board Following Her Retirement Justin Mennen to Succeed Leslie C.G. Campbell as Chair…
Sep 14, 2026
Press release
PetMeds Appoints Andrew Parry as Chief Technology Officer
DELRAY BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today…
Aug 13, 2026
Earnings date
PETS Q1 2027 Earnings Scheduled — 2026-08-13

SecBot reports

7 filings · 3 press releases · 0 bullish · 2 bearish · 5 neutral
All PETS filing & press-release reports (10)